Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women

Introduction: breast cancer is the most diagnosed type of cancer and the leading cause of death among women worldwide. Approximately 1.67 million new cases of breast cancer were diagnosed in 2012, leading to more than half a million deaths. Breast cancer accounted for 11.6% of newly diagnosed cancer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista brasileira de crescimento e desenvolvimento humano 2022, Vol.32 (2), p.242-247
Hauptverfasser: Guilherme Varotti Pereira, Rodrigo, Peres Souto, Ricardo, Larcher Longo, Priscila, Eduardo Fernandes, César, Carelli Filho, Ivo, Tadeu Felizi, Rogério, Gonzales Veiga, Melissa, De Oliveira, Emerson
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 247
container_issue 2
container_start_page 242
container_title Revista brasileira de crescimento e desenvolvimento humano
container_volume 32
creator Guilherme Varotti Pereira, Rodrigo
Peres Souto, Ricardo
Larcher Longo, Priscila
Eduardo Fernandes, César
Carelli Filho, Ivo
Tadeu Felizi, Rogério
Gonzales Veiga, Melissa
De Oliveira, Emerson
description Introduction: breast cancer is the most diagnosed type of cancer and the leading cause of death among women worldwide. Approximately 1.67 million new cases of breast cancer were diagnosed in 2012, leading to more than half a million deaths. Breast cancer accounted for 11.6% of newly diagnosed cancers (2,089 million) and 9.2% (787,000) of cancer-related deaths for both sexes and at all ages worldwide in 2018. Objective: breast cancer, as the most diagnosed carcinoma in the world and the leading cause of death among women, is a morbidity of outstanding importance, and the object of this study is to evaluate the association between the LOX gene G473A (rs1800449) polymorphism and breast cancer occurrence, potentially establishing a new finding in the identification of risks, prevention, and care for a specific group of women. Methods:in this retrospective cohort study, LOX G473A polymorphism frequency was assessed in 148 women with breast cancer and 245 women without breast cancer. All patients completed a questionnaire to identify possible risk factors and subsequently underwent peripheral blood collection to study the LOX gene. DNA was extracted followed by gene amplification via PCR, and the polymorphism was studied by specific fragment electrophoresis after digestion of the samples with the restriction endonuclease Pstl. Results: this study identified the use of oral contraceptives and family history of breast cancer as risk factors for breast cancer; the G473A polymorphism in LOX was not identified as a risk factor. Conclusion: a relationship was not observed between the LOX G473A polymorphism and the occurrence of breast cancer. Introdução: o câncer de mama é o tipo de câncer mais diagnosticado e a principal causa de morte entre as mulheres em todo o mundo. Aproximadamente 1,67 milhões de novos casos de câncer de mama foram diagnosticados em 2012, levando a mais de meio milhão de mortes. O câncer de mama foi responsável por 11,6% dos novos casos de cânceres diagnosticados (2.089 milhões) e 9,2% (787.000) das mortes relacionadas ao câncer para ambos os sexos e em todas as idades em todo o mundo em 2018. Objetivo: o câncer de mama como o carcinoma mais diagnosticado no mundo e a principal causa de morte entre as mulheres, é uma morbidade de grande importância, sendo o objetivo deste estudo avaliar a associação entre o polimorfismo do gene LOX G473A (rs1800449) a ocorrência de câncer de mama, potencialmente estabelecendo um novo achado na identificação de r
doi_str_mv 10.36311/jhgd.v32.13317
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2681625051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2681625051</sourcerecordid><originalsourceid>FETCH-LOGICAL-c138t-5cc1336527a1051bbbc7b1091973cef21797f1cfb6e9b2df621e225218c436c73</originalsourceid><addsrcrecordid>eNotkM1OwzAQhC0EElXpmaslzmm9duMkR1SVH6kSFzhbtmO3KUkc7KQQ3oF3xg3sZbTa2Vnth9AtkCXjDGB1POzL5YnRJTAG2QWaUcjShKVFfolmBMg6AZrTa7QI4UhiRVdB-Az9bE-yHmRfuRY7i_uDwft1xiTuXD02zneHKjS4aqdJPYaxxu6rKmWIPtMaLAOW2FfhHVupe-exN7XsTYl7N604rQfvTavNOV55I0OPtYy9P6cqL7-rupIt_nSNaW_QlZV1MIt_naO3h-3r5inZvTw-b-53iQaW90mqozKe0kwCSUEppTMFpIAiY9rY-HqRWdBWcVMoWlpOwVCaUsj1mnGdsTm6-8vtvPsYTOjF0Q2-jScF5TlwmsbY6Fr9ubR3IXhjReerRvpRABETdnHGLiJ2MWFnv6BMd00</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2681625051</pqid></control><display><type>article</type><title>Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Guilherme Varotti Pereira, Rodrigo ; Peres Souto, Ricardo ; Larcher Longo, Priscila ; Eduardo Fernandes, César ; Carelli Filho, Ivo ; Tadeu Felizi, Rogério ; Gonzales Veiga, Melissa ; De Oliveira, Emerson</creator><creatorcontrib>Guilherme Varotti Pereira, Rodrigo ; Peres Souto, Ricardo ; Larcher Longo, Priscila ; Eduardo Fernandes, César ; Carelli Filho, Ivo ; Tadeu Felizi, Rogério ; Gonzales Veiga, Melissa ; De Oliveira, Emerson</creatorcontrib><description>Introduction: breast cancer is the most diagnosed type of cancer and the leading cause of death among women worldwide. Approximately 1.67 million new cases of breast cancer were diagnosed in 2012, leading to more than half a million deaths. Breast cancer accounted for 11.6% of newly diagnosed cancers (2,089 million) and 9.2% (787,000) of cancer-related deaths for both sexes and at all ages worldwide in 2018. Objective: breast cancer, as the most diagnosed carcinoma in the world and the leading cause of death among women, is a morbidity of outstanding importance, and the object of this study is to evaluate the association between the LOX gene G473A (rs1800449) polymorphism and breast cancer occurrence, potentially establishing a new finding in the identification of risks, prevention, and care for a specific group of women. Methods:in this retrospective cohort study, LOX G473A polymorphism frequency was assessed in 148 women with breast cancer and 245 women without breast cancer. All patients completed a questionnaire to identify possible risk factors and subsequently underwent peripheral blood collection to study the LOX gene. DNA was extracted followed by gene amplification via PCR, and the polymorphism was studied by specific fragment electrophoresis after digestion of the samples with the restriction endonuclease Pstl. Results: this study identified the use of oral contraceptives and family history of breast cancer as risk factors for breast cancer; the G473A polymorphism in LOX was not identified as a risk factor. Conclusion: a relationship was not observed between the LOX G473A polymorphism and the occurrence of breast cancer. Introdução: o câncer de mama é o tipo de câncer mais diagnosticado e a principal causa de morte entre as mulheres em todo o mundo. Aproximadamente 1,67 milhões de novos casos de câncer de mama foram diagnosticados em 2012, levando a mais de meio milhão de mortes. O câncer de mama foi responsável por 11,6% dos novos casos de cânceres diagnosticados (2.089 milhões) e 9,2% (787.000) das mortes relacionadas ao câncer para ambos os sexos e em todas as idades em todo o mundo em 2018. Objetivo: o câncer de mama como o carcinoma mais diagnosticado no mundo e a principal causa de morte entre as mulheres, é uma morbidade de grande importância, sendo o objetivo deste estudo avaliar a associação entre o polimorfismo do gene LOX G473A (rs1800449) a ocorrência de câncer de mama, potencialmente estabelecendo um novo achado na identificação de riscos, prevenção, e atendimento a um grupo específico de mulheres. Método: neste estudo de coorte retrospectivo, a frequência do polimorfismo LOX G473A foi avaliada em 148 mulheres com câncer de mama e 245 mulheres sem a doença. Todas as pacientes responderam a um questionário para identificação de possíveis fatores de risco e posteriormente realizaram coleta de sangue periférico para estudo do gene LOX. O DNA foi extraído seguido da amplificação gênica via PCR, e o polimorfismo foi estudado por eletroforese de fragmentos específicos após digestão das amostras com a endonuclease de restrição do organismo Providencia stuartii. Resultados: este estudo identificou o uso de anticoncepcional oral e o antecedente familiar de câncer de mama como fatores de risco par a doença; o polimorfismo G473A na LOX não foi identificado como fator de risco. Conclusão: não foi observada relação entre o polimorfismo LOX G473A e a ocorrência de câncer de mama.</description><identifier>ISSN: 0104-1282</identifier><identifier>EISSN: 2175-3598</identifier><identifier>DOI: 10.36311/jhgd.v32.13317</identifier><language>eng</language><publisher>Sao Paulo: Journal of Human Growth and Development</publisher><subject>Breast cancer ; Deoxyribonucleic acid ; DNA ; Endonuclease ; Gene amplification ; Gene polymorphism ; LOX gene ; Lysyl oxidase ; Morbidity ; Oral contraceptives ; Peripheral blood ; Polymerase chain reaction ; Polymorphism ; Risk assessment ; Risk factors</subject><ispartof>Revista brasileira de crescimento e desenvolvimento humano, 2022, Vol.32 (2), p.242-247</ispartof><rights>2022. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,4010,27900,27901,27902</link.rule.ids></links><search><creatorcontrib>Guilherme Varotti Pereira, Rodrigo</creatorcontrib><creatorcontrib>Peres Souto, Ricardo</creatorcontrib><creatorcontrib>Larcher Longo, Priscila</creatorcontrib><creatorcontrib>Eduardo Fernandes, César</creatorcontrib><creatorcontrib>Carelli Filho, Ivo</creatorcontrib><creatorcontrib>Tadeu Felizi, Rogério</creatorcontrib><creatorcontrib>Gonzales Veiga, Melissa</creatorcontrib><creatorcontrib>De Oliveira, Emerson</creatorcontrib><title>Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women</title><title>Revista brasileira de crescimento e desenvolvimento humano</title><description>Introduction: breast cancer is the most diagnosed type of cancer and the leading cause of death among women worldwide. Approximately 1.67 million new cases of breast cancer were diagnosed in 2012, leading to more than half a million deaths. Breast cancer accounted for 11.6% of newly diagnosed cancers (2,089 million) and 9.2% (787,000) of cancer-related deaths for both sexes and at all ages worldwide in 2018. Objective: breast cancer, as the most diagnosed carcinoma in the world and the leading cause of death among women, is a morbidity of outstanding importance, and the object of this study is to evaluate the association between the LOX gene G473A (rs1800449) polymorphism and breast cancer occurrence, potentially establishing a new finding in the identification of risks, prevention, and care for a specific group of women. Methods:in this retrospective cohort study, LOX G473A polymorphism frequency was assessed in 148 women with breast cancer and 245 women without breast cancer. All patients completed a questionnaire to identify possible risk factors and subsequently underwent peripheral blood collection to study the LOX gene. DNA was extracted followed by gene amplification via PCR, and the polymorphism was studied by specific fragment electrophoresis after digestion of the samples with the restriction endonuclease Pstl. Results: this study identified the use of oral contraceptives and family history of breast cancer as risk factors for breast cancer; the G473A polymorphism in LOX was not identified as a risk factor. Conclusion: a relationship was not observed between the LOX G473A polymorphism and the occurrence of breast cancer. Introdução: o câncer de mama é o tipo de câncer mais diagnosticado e a principal causa de morte entre as mulheres em todo o mundo. Aproximadamente 1,67 milhões de novos casos de câncer de mama foram diagnosticados em 2012, levando a mais de meio milhão de mortes. O câncer de mama foi responsável por 11,6% dos novos casos de cânceres diagnosticados (2.089 milhões) e 9,2% (787.000) das mortes relacionadas ao câncer para ambos os sexos e em todas as idades em todo o mundo em 2018. Objetivo: o câncer de mama como o carcinoma mais diagnosticado no mundo e a principal causa de morte entre as mulheres, é uma morbidade de grande importância, sendo o objetivo deste estudo avaliar a associação entre o polimorfismo do gene LOX G473A (rs1800449) a ocorrência de câncer de mama, potencialmente estabelecendo um novo achado na identificação de riscos, prevenção, e atendimento a um grupo específico de mulheres. Método: neste estudo de coorte retrospectivo, a frequência do polimorfismo LOX G473A foi avaliada em 148 mulheres com câncer de mama e 245 mulheres sem a doença. Todas as pacientes responderam a um questionário para identificação de possíveis fatores de risco e posteriormente realizaram coleta de sangue periférico para estudo do gene LOX. O DNA foi extraído seguido da amplificação gênica via PCR, e o polimorfismo foi estudado por eletroforese de fragmentos específicos após digestão das amostras com a endonuclease de restrição do organismo Providencia stuartii. Resultados: este estudo identificou o uso de anticoncepcional oral e o antecedente familiar de câncer de mama como fatores de risco par a doença; o polimorfismo G473A na LOX não foi identificado como fator de risco. Conclusão: não foi observada relação entre o polimorfismo LOX G473A e a ocorrência de câncer de mama.</description><subject>Breast cancer</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Endonuclease</subject><subject>Gene amplification</subject><subject>Gene polymorphism</subject><subject>LOX gene</subject><subject>Lysyl oxidase</subject><subject>Morbidity</subject><subject>Oral contraceptives</subject><subject>Peripheral blood</subject><subject>Polymerase chain reaction</subject><subject>Polymorphism</subject><subject>Risk assessment</subject><subject>Risk factors</subject><issn>0104-1282</issn><issn>2175-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotkM1OwzAQhC0EElXpmaslzmm9duMkR1SVH6kSFzhbtmO3KUkc7KQQ3oF3xg3sZbTa2Vnth9AtkCXjDGB1POzL5YnRJTAG2QWaUcjShKVFfolmBMg6AZrTa7QI4UhiRVdB-Az9bE-yHmRfuRY7i_uDwft1xiTuXD02zneHKjS4aqdJPYaxxu6rKmWIPtMaLAOW2FfhHVupe-exN7XsTYl7N604rQfvTavNOV55I0OPtYy9P6cqL7-rupIt_nSNaW_QlZV1MIt_naO3h-3r5inZvTw-b-53iQaW90mqozKe0kwCSUEppTMFpIAiY9rY-HqRWdBWcVMoWlpOwVCaUsj1mnGdsTm6-8vtvPsYTOjF0Q2-jScF5TlwmsbY6Fr9ubR3IXhjReerRvpRABETdnHGLiJ2MWFnv6BMd00</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Guilherme Varotti Pereira, Rodrigo</creator><creator>Peres Souto, Ricardo</creator><creator>Larcher Longo, Priscila</creator><creator>Eduardo Fernandes, César</creator><creator>Carelli Filho, Ivo</creator><creator>Tadeu Felizi, Rogério</creator><creator>Gonzales Veiga, Melissa</creator><creator>De Oliveira, Emerson</creator><general>Journal of Human Growth and Development</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PKEHL</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2022</creationdate><title>Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women</title><author>Guilherme Varotti Pereira, Rodrigo ; Peres Souto, Ricardo ; Larcher Longo, Priscila ; Eduardo Fernandes, César ; Carelli Filho, Ivo ; Tadeu Felizi, Rogério ; Gonzales Veiga, Melissa ; De Oliveira, Emerson</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c138t-5cc1336527a1051bbbc7b1091973cef21797f1cfb6e9b2df621e225218c436c73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Breast cancer</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Endonuclease</topic><topic>Gene amplification</topic><topic>Gene polymorphism</topic><topic>LOX gene</topic><topic>Lysyl oxidase</topic><topic>Morbidity</topic><topic>Oral contraceptives</topic><topic>Peripheral blood</topic><topic>Polymerase chain reaction</topic><topic>Polymorphism</topic><topic>Risk assessment</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guilherme Varotti Pereira, Rodrigo</creatorcontrib><creatorcontrib>Peres Souto, Ricardo</creatorcontrib><creatorcontrib>Larcher Longo, Priscila</creatorcontrib><creatorcontrib>Eduardo Fernandes, César</creatorcontrib><creatorcontrib>Carelli Filho, Ivo</creatorcontrib><creatorcontrib>Tadeu Felizi, Rogério</creatorcontrib><creatorcontrib>Gonzales Veiga, Melissa</creatorcontrib><creatorcontrib>De Oliveira, Emerson</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied &amp; Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Revista brasileira de crescimento e desenvolvimento humano</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guilherme Varotti Pereira, Rodrigo</au><au>Peres Souto, Ricardo</au><au>Larcher Longo, Priscila</au><au>Eduardo Fernandes, César</au><au>Carelli Filho, Ivo</au><au>Tadeu Felizi, Rogério</au><au>Gonzales Veiga, Melissa</au><au>De Oliveira, Emerson</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women</atitle><jtitle>Revista brasileira de crescimento e desenvolvimento humano</jtitle><date>2022</date><risdate>2022</risdate><volume>32</volume><issue>2</issue><spage>242</spage><epage>247</epage><pages>242-247</pages><issn>0104-1282</issn><eissn>2175-3598</eissn><abstract>Introduction: breast cancer is the most diagnosed type of cancer and the leading cause of death among women worldwide. Approximately 1.67 million new cases of breast cancer were diagnosed in 2012, leading to more than half a million deaths. Breast cancer accounted for 11.6% of newly diagnosed cancers (2,089 million) and 9.2% (787,000) of cancer-related deaths for both sexes and at all ages worldwide in 2018. Objective: breast cancer, as the most diagnosed carcinoma in the world and the leading cause of death among women, is a morbidity of outstanding importance, and the object of this study is to evaluate the association between the LOX gene G473A (rs1800449) polymorphism and breast cancer occurrence, potentially establishing a new finding in the identification of risks, prevention, and care for a specific group of women. Methods:in this retrospective cohort study, LOX G473A polymorphism frequency was assessed in 148 women with breast cancer and 245 women without breast cancer. All patients completed a questionnaire to identify possible risk factors and subsequently underwent peripheral blood collection to study the LOX gene. DNA was extracted followed by gene amplification via PCR, and the polymorphism was studied by specific fragment electrophoresis after digestion of the samples with the restriction endonuclease Pstl. Results: this study identified the use of oral contraceptives and family history of breast cancer as risk factors for breast cancer; the G473A polymorphism in LOX was not identified as a risk factor. Conclusion: a relationship was not observed between the LOX G473A polymorphism and the occurrence of breast cancer. Introdução: o câncer de mama é o tipo de câncer mais diagnosticado e a principal causa de morte entre as mulheres em todo o mundo. Aproximadamente 1,67 milhões de novos casos de câncer de mama foram diagnosticados em 2012, levando a mais de meio milhão de mortes. O câncer de mama foi responsável por 11,6% dos novos casos de cânceres diagnosticados (2.089 milhões) e 9,2% (787.000) das mortes relacionadas ao câncer para ambos os sexos e em todas as idades em todo o mundo em 2018. Objetivo: o câncer de mama como o carcinoma mais diagnosticado no mundo e a principal causa de morte entre as mulheres, é uma morbidade de grande importância, sendo o objetivo deste estudo avaliar a associação entre o polimorfismo do gene LOX G473A (rs1800449) a ocorrência de câncer de mama, potencialmente estabelecendo um novo achado na identificação de riscos, prevenção, e atendimento a um grupo específico de mulheres. Método: neste estudo de coorte retrospectivo, a frequência do polimorfismo LOX G473A foi avaliada em 148 mulheres com câncer de mama e 245 mulheres sem a doença. Todas as pacientes responderam a um questionário para identificação de possíveis fatores de risco e posteriormente realizaram coleta de sangue periférico para estudo do gene LOX. O DNA foi extraído seguido da amplificação gênica via PCR, e o polimorfismo foi estudado por eletroforese de fragmentos específicos após digestão das amostras com a endonuclease de restrição do organismo Providencia stuartii. Resultados: este estudo identificou o uso de anticoncepcional oral e o antecedente familiar de câncer de mama como fatores de risco par a doença; o polimorfismo G473A na LOX não foi identificado como fator de risco. Conclusão: não foi observada relação entre o polimorfismo LOX G473A e a ocorrência de câncer de mama.</abstract><cop>Sao Paulo</cop><pub>Journal of Human Growth and Development</pub><doi>10.36311/jhgd.v32.13317</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0104-1282
ispartof Revista brasileira de crescimento e desenvolvimento humano, 2022, Vol.32 (2), p.242-247
issn 0104-1282
2175-3598
language eng
recordid cdi_proquest_journals_2681625051
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Breast cancer
Deoxyribonucleic acid
DNA
Endonuclease
Gene amplification
Gene polymorphism
LOX gene
Lysyl oxidase
Morbidity
Oral contraceptives
Peripheral blood
Polymerase chain reaction
Polymorphism
Risk assessment
Risk factors
title Evaluation of the g473a polymorphism in the lysyl oxidase gene as a risk factor related to the occurrence of breast cancer in brazilian women
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T00%3A39%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20the%20g473a%20polymorphism%20in%20the%20lysyl%20oxidase%20gene%20as%20a%20risk%20factor%20related%20to%20the%20occurrence%20of%20breast%20cancer%20in%20brazilian%20women&rft.jtitle=Revista%20brasileira%20de%20crescimento%20e%20desenvolvimento%20humano&rft.au=Guilherme%20Varotti%20Pereira,%20Rodrigo&rft.date=2022&rft.volume=32&rft.issue=2&rft.spage=242&rft.epage=247&rft.pages=242-247&rft.issn=0104-1282&rft.eissn=2175-3598&rft_id=info:doi/10.36311/jhgd.v32.13317&rft_dat=%3Cproquest_cross%3E2681625051%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2681625051&rft_id=info:pmid/&rfr_iscdi=true